Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-15 · accession 0001438133-21-000207 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-17 | 2021-11-15 | TNDM | Leal James | SVP, Ops | A - Grant | $69.39 | +101 | 3,852 | +3% | +$7,008 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-15 | A | A | 101 | $69.39 | 3,852 | D | — | — | (F1) The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of May 18, 2021 through November 15, 2021. This transaction is also exempt under Rule 16b-3(c). |